ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524824 announcements Bal Pharma announcements and dividends declared BSE

Bal Pharma Complete list of announcements declared & dividend announcements by Bal Pharma 524824

Bal Pharma 524824 listed on BSE and deals in

Announcements and dividends declared by Bal Pharma 524824

China holds all the cards in global pharmaceuticals despite India’s bid to reshuffle the deck
China's dominance over raw materials for medicines presents a significant supply-chain vulnerability for the US. A US commission urges Congress to require pharmaceutical firms to report supply chain origins and encourage diversification away from China, hi
Announcement as on 26 November 2025

China’s biotech is redrawing the global pharma map; what India can learn
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. AstraZeneca signed a deal with CSPC Pharma for a cardiac treatment, while Merck signed a billion deal with Hansoh Phar
Announcement as on 15 March 2025

India becoming an attractive option for global pharmaceutical supply chain: Macquarie Report
India's CRDMO industry is projected to grow from USD 7 billion to USD 14 billion by 2028, driven by pharmaceutical outsourcing and regulatory support. The industry's growth could reach a high-teens CAGR due to factors like the US Biosecure Act, potentially
Announcement as on 20 February 2025

China+1 opens larger share for India in global pharma manufacturing beyond generics: BCG report
India is set to capture a larger share of the global pharmaceutical market beyond generics, driven by the "China+1" strategy as companies diversify from China. Investments are pouring into India's affordable pharma services and growing infrastructure. Indi
Announcement as on 27 January 2025

Aurobindo joins hands with global pharma player to develop respiratory products
Aurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collaboration involves a shared cost of up to million over three to five years, with both companies sharing marketing righ
Announcement as on 23 November 2024

Announcements by Bal Pharma first page | Next page |

524824 Bal Pharma current price & indicator signals

Moving Averages for Bal Pharma

  • 5Day Average: 73.72
  • 12Day Average: 73.41
  • 20Day Average: 73.57
  • 50Day Average: 77.55
  • 100Day Average: 82.89
  • 150Day Average: 88.58
  • 200Day Average: 90.25

524824 Indicators & signals

Indicator MACD (12,26,9)

73.53, 74.71, -1.47
Indicator MACD is in negative zone

Indicator ADX (14)

9.62, 17.54, 21.27
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524824 Bal Pharma are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Fri Dec 2025 72.02 71.02 to 73.00 -2.73% 2.67 times
24 Wed Dec 2025 74.04 72.98 to 74.24 -0.15% 0.39 times
23 Tue Dec 2025 74.15 73.00 to 74.80 0.97% 2.37 times
22 Mon Dec 2025 73.44 73.25 to 74.75 -2% 0.07 times
19 Fri Dec 2025 74.94 73.60 to 74.94 3.01% 0.31 times
18 Thu Dec 2025 72.75 72.57 to 74.99 -0.79% 0.27 times
17 Wed Dec 2025 73.33 72.57 to 76.99 1.35% 0.42 times
16 Tue Dec 2025 72.35 71.50 to 74.01 -3.09% 0.84 times
15 Mon Dec 2025 74.66 71.50 to 75.71 1.55% 0.79 times
12 Fri Dec 2025 73.52 72.96 to 74.44 1.58% 3.56 times
11 Thu Dec 2025 72.38 71.01 to 73.73 -1.34% 0.99 times
10 Wed Dec 2025 73.36 71.30 to 74.99 0.12% 1.2 times

Videos related to: 524824 announcements Bal Pharma announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524824 announcements Bal Pharma announcements and dividends declared BSE

 

Back to top